Sign inGet started

Bumpus Namandje

Insider CIK 2060594 · RXRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RXRX RECURSION PHARMACEUTICALS, S Sale2026-06-182026-06-223,963$3.18 $12.6K127,632SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2026-06-172026-06-2288,424— $0131,595SEC↗
RXRX RECURSION PHARMACEUTICALS, S Sale2026-06-032026-06-044,386$3.54 $15.5K43,171SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2025-06-182025-06-2322,016— $022,016SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2025-06-182025-06-2311,008— $047,557SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award deriv2025-03-172025-03-1973,099— $073,099SEC↗
RXRX RECURSION PHARMACEUTICALS, A Award2025-03-172025-03-1936,549— $036,549SEC↗